Aryl hydrocarbon receptor is critical for enzalutamide-resistant prostate cancer growth

被引：0
|
作者：
Chen, Chia-Hui
Wu, Boyang Jason
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5837
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5837
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
    Eliot B. Blatt
    Karla Parra
    Antje Neeb
    Lorenzo Buroni
    Denisa Bogdan
    Wei Yuan
    Yunpeng Gao
    Collin Gilbreath
    Alec Paschalis
    Suzanne Carreira
    Ralph J. DeBerardinis
    Ram S. Mani
    Johann S. de Bono
    Ganesh V. Raj
    Oncogene, 2023, 42 : 2347 - 2359
  • [2] Critical role of antioxidant programs in enzalutamide-resistant prostate cancer
    Blatt, Eliot B.
    Parra, Karla
    Neeb, Antje
    Buroni, Lorenzo
    Bogdan, Denisa
    Yuan, Wei
    Gao, Yunpeng
    Gilbreath, Collin
    Paschalis, Alec
    Carreira, Suzanne
    DeBerardinis, Ralph J.
    Mani, Ram S.
    de Bono, Johann S.
    Raj, Ganesh V.
    ONCOGENE, 2023, 42 (30) : 2347 - 2359
  • [3] MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Bhattacharjee, Sayani
    Wynn, Rebecca
    Sindhwani, Puneet
    Petros, Firas
    Nadiminty, Nagalakshmi
    JOURNAL OF UROLOGY, 2023, 209 : E146 - E146
  • [4] Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer
    Thomas, Lewis
    Baratchian, Mehdi
    Sharifi, Nima
    EUROPEAN UROLOGY, 2020, 77 (02) : 156 - 157
  • [5] Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
    Tucci, Marcello
    Zichi, Clizia
    Buttigliero, Consuelo
    Vignani, Francesca
    Scagliotti, Giorgio V.
    Di Maio, Massimo
    ONCOTARGETS AND THERAPY, 2018, 11 : 7353 - 7368
  • [6] DO EXOSOMES CONTRIBUTE TO THE DEVELOPMENT OF ENZALUTAMIDE-RESISTANT PROSTATE CANCER?
    Peak, Taylor
    Panigrahi, Gati
    Praharaj, Prakash
    Chavez, Jose
    Chyr, Jacqueline
    Singh, Ravi
    Griend, Donald Vander
    Bitting, Rhonda
    Hemal, Ashok
    Deep, Gagan
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1224 - E1224
  • [7] Pathways to enzalutamide resistance: An analysis of proteomic changes in enzalutamide-resistant prostate cancer cells
    Molokwu, Chidi N.
    Kristensen, Anders
    Sutton, Chris
    CANCER RESEARCH, 2024, 84 (03)
  • [8] AMINO ACID TRANSPORT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE
    Seyan, Zheyar J.
    Wolpert, John
    Stroever, Stephanie
    de Riese, Werner T. W.
    JOURNAL OF UROLOGY, 2024, 211 (05): : E49 - E49
  • [9] Upregulation of glucocorticoid receptor-mediated glucose transporter 4 in enzalutamide-resistant prostate cancer
    Hoshi, Seiji
    Meguro, Satoru
    Imai, Hitomi
    Matsuoka, Yuta
    Yoshida, Yuki
    Onagi, Akihumi
    Tanji, Ryo
    Honda-Takinami, Ruriko
    Matsuoka, Kanako
    Koguchi, Tomoyuki
    Hata, Junya
    Sato, Yuichi
    Akaihata, Hidenori
    Kataoka, Masao
    Ogawa, Soichiro
    Kojima, Yoshiyuki
    CANCER SCIENCE, 2021, 112 (05) : 1899 - 1910
  • [10] Aberrant tumor metabolism to enable glucocorticoid receptor takeover in enzalutamide-resistant prostate cancer.
    Sharifi, Nima
    Li, Jianneng
    Alyamani, Mohammad
    Zhang, Ao
    Chang, Kai-Hsiung
    Berk, Mike
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345